|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"lu ys"
Showing items 16-44 of 44 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國家衛生研究院 |
2009-09-15 |
Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma
|
Ou, DL;Shen, YC;Liang, JD;Liou, JY;Yu, SL;Fan, HH;Wang, DS;Lu, YS;Hsu, C;Cheng, AL |
| 國家衛生研究院 |
2009-06 |
Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia
|
Lin, CH;Liau, JY;Lu, YS;Huang, CS;Lee, WC;Kuo, KT;Shen, YC;Kuo, SH;Lan, C;Liu, JM;Kuo, WH;Chang, KJ;Cheng, AL |
| 國家衛生研究院 |
2009-04-24 |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen, KF;Yeh, PY;Hsu, C;Hsu, CH;Lu, YS;Hsieh, HP;Chen, PJ;Cheng, AL |
| 國立臺灣大學 |
2008-11 |
OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma.
|
Gao, M; Yeh, PY; Lu, YS; Hsu, CH; Chen, KF; Lee, WC; Feng, WC; Chen, CS; Kuo, ML; Cheng, AL |
| 國立臺灣大學 |
2008-11 |
NF-kappaB p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells.
|
Gao, M; Yeh, PY; Lu, YS; Chang, WC; Kuo, ML; Cheng, AL |
| 國家衛生研究院 |
2008-08 |
Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells
|
Chen, KF;Yeh, PY;Yeh, KH;Lu, YS;Huang, SY;Cheng, AL |
| 國立臺灣大學 |
2008-06 |
Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients.
|
Kuo, SH; Lien, HC; You, SL; Lu, YS; Lin, CH; Chen, TZ; Huang, CS. |
| 國立臺灣大學 |
2008-06 |
The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers.
|
Huang, CS; Kuo, SH; Lien, HC; Yang, SY; You, SL; Shen, CY; Lin, CH; Lu, YS; Chang, KJ. |
| 國立臺灣大學 |
2008-02 |
Differential expression of glucocorticoid receptor in carcinomas of the human digestive system
|
Lien, HC; Lu, YS; Shun, CT; Yao, YT; Chang, WC; Cheng, AL |
| 國家衛生研究院 |
2007-06-01 |
Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation
|
Chen, CS; Wang, YC; Yang, HC; Huang, PH; Kulp, SK; Yang, CC; Lu, YS; Matsuyama, S; Chen, CY; Chen, CS |
| 國立臺灣大學 |
2007-03 |
Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation.
|
Chen, CS; Wang, YC; Yang, HC; Huang, PH; Kulp, SK; Yang, CC; Lu, YS; Matsuyama, S; Chen, CY; Chen, CS |
| 國立臺灣大學 |
2007-02 |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer.
|
Lin, CC; Cheng, AL; Hsu, CH; Lu, YS; Hsu, C; Kun-Huei, Yeh; Wu, CY; Huang, CS; Yang, CH. |
| 國立臺灣大學 |
2007-02 |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer.
|
Lin, CC; Cheng, AL; Hsu, CH; Lu, YS; Hsu, C; Kun-Huei, Yeh; Wu, CY; Huang, CS; Yang, CH. |
| 國立臺灣大學 |
2006-12 |
Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors.
|
Lu, YS; Lien, HC; Yeh, PY; Yeh, KH; Kuo, ML; Kuo, SH; Cheng, AL. |
| 國家衛生研究院 |
2006-05 |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang, HJ; Wang, CC; Cheng, AL; Hsu, C; Lu, YS; Chang, MC; Lin, JT; Wang, HP; Shiah, HS; Liu, TW; Chang, JY; Whang-Peng, J; Chen, LT |
| 國家衛生研究院 |
2006-02 |
Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-kappa B activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa
|
Lu, YS; Yeh, PY; Chuang, SE; Gao, M; Kuo, ML; Cheng, AL |
| 國立臺灣大學 |
2005-10 |
Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors.
|
Lu, YS; Lien, HC; Yeh, PY; Kun-Huei, Yeh; Kuo, ML; Kuo, SH; Cheng, AL |
| 國家衛生研究院 |
2005-09-14 |
Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients
|
Su, WP;Wen, CC;Hsiung, CA;Su, IJ;Cheng, AL;Chang, MC;Tsao, CJ;Kao, WY;Uen, WC;Hsu, CH;Lu, YS;Tien, HF;Chao, TY;Chen, LT;Whang-Peng, J;Chen, PJ |
| 國立臺灣大學 |
2005-08 |
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer.
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL. |
| 國立臺灣大學 |
2005-08 |
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer.
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL. |
| 國立臺灣大學 |
2005-06 |
Phase II study of weekly vinorelbine and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer.
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Cheng, AL. |
| 國立臺灣大學 |
2005-06 |
Phase II study of weekly vinorelbine and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer.
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Cheng, AL. |
| 國家衛生研究院 |
2005-03-28 |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Yang, CH; Cheng, AL |
| 國家衛生研究院 |
2005 |
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL |
| 國家衛生研究院 |
2004-05-04 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Hsu, C; Shen, YC; Yang, CH; Yeh, KH; Lu, YS; Hsu, CH; Liu, HT; Li, CC; Chen, JS; Wu, CY; Cheng, AL |
| 國立臺灣大學 |
2004-05 |
Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma.
|
Lu, YS; Hsu, C; Li, CC; Kuo, SH; Kun-Huei, Yeh; Yang, CH; Hsu, CH; Wu, CY; Cheng, AL. |
| 國立臺灣大學 |
2004-05 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.
|
Hsu C; Shen YC; Yang CH; Kun-Huei Yeh; Lu YS; Hsu CH; Liu HT; Li CC; Chen JS; Wu CY; Cheng AL |
| 臺大學術典藏 |
2004-05 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.
|
Hsu C;Shen YC;Yang CH;Kun-Huei Yeh;Lu YS;Hsu CH;Liu HT;Li CC;Chen JS;Wu CY;Cheng AL; Hsu C; Shen YC; Yang CH; Kun-Huei Yeh; Lu YS; Hsu CH; Liu HT; Li CC; Chen JS; Wu CY; Cheng AL |
| 國家衛生研究院 |
2002-05-01 |
Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappa B (NF-kappa B), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells
|
Chuang, SE; Yeh, PY; Lu, YS; Lai, GM; Liao, CM; Gao, M; Cheng, AL |
Showing items 16-44 of 44 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
